Cognition Therapeutics logo

Cognition Therapeutics

CGTX | NASDAQ
Chart Builder DCF Calculator
$0.64
-$0.04 (-5.85%)
At close: Nov 16, 2026, 4:00 PM ET
$0.64
$0.00 (-0.47%)
After-hours: Nov 16, 2026, 7:26 PM ET
-5.85%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #603/1021 (Top 59%)

Key Statistics

Market Data

Market Cap $60.75M
1D Range
0.61 0.69
52W Range
0.59 1.80

Valuation (TTM)

PE -3.76
PB 2.08
EV/EBITDA -1.93

Valuation (NTM)

Forward PE N/A
Forward PEG 0.08
Price Target $3.00
Loading financial charts...

Profile

Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments. The firm's research and development efforts are prima...

Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Oct 8, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$3.00
Upside
+368.75%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.